论文部分内容阅读
我国生物技术领域重点课题——“肝癌导向药物研究”现已经过第四军医大学病理教研室10名专家教授历时16年的刻苦攻关,取得了突破性的进展,并得到国内外同行的关注。 他们率先在国内外研制出一种能自动识别癌细胞并能携带两种抗癌物质的“双弹头”新型“生物导弹”,并用其攻击肝癌病变区获得成功,使人类征服癌症有了新的希望,它标志着我国在肝癌诊断治疗方面已经步入世
The key research topic in the field of biotechnology in China, “Research on liver cancer-directed drugs”, has now passed 10 years of research in the pathology department of the Fourth Military Medical University. It has made breakthroughs and achieved remarkable progress and gained attention from domestic and foreign counterparts. They took the lead in developing a new type of “bi-warhead” new “bio-missile” capable of automatically recognizing cancerous cells and carrying two kinds of anti-cancer substances at home and abroad, and succeeded in using it to attack the lesion area of liver cancer, so that humans have conquered cancer with new ones. Hopefully, it indicates that China has entered the world in the diagnosis and treatment of liver cancer.